SVB Leerink Starts Johnson & Johnson (JNJ) at Outperform Citing Favorable Financial Strength

May 23, 2022 3:47 AM EDT Send to a Friend
SVB Leerink analyst David Risinger initiates coverage on Johnson & Johnson (NYSE: JNJ) with a Outperform rating and a price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login